Magnetar Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History

Magnetar Financial’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,955	Closed	-$702K	–	952
2025 Q3	$702K	Sell	12,955 -14,290	-52%	-$817K	﹤0.01%	523
2025 Q2	$1.5M	Buy	+27,245	New	+$1.6M	0.01%	376
2024 Q4	–	Sell	-3,404	Closed	-$239K	–	624
2024 Q3	$239K	Sell	3,404 -5,412	-61%	-$452K	0.01%	441
2024 Q2	$726K	Buy	+8,816	New	+$734K	0.02%	302
2022 Q2	–	Sell	-3,169	Closed	-$244K	–	1678
2022 Q1	$244K	Buy	+3,169	New	+$265K	﹤0.01%	1026
2021 Q2	–	Sell	-6,287	Closed	-$475K	–	1216
2021 Q1	$475K	Buy	6,287 +1,776	+39%	+$145K	﹤0.01%	834
2020 Q4	$396K	Buy	+4,511	New	+$358K	0.01%	592
2019 Q2	–	Sell	-4,242	Closed	-$377K	–	453
2019 Q1	$377K	Buy	+4,242	New	+$393K	0.01%	291
2017 Q2	–	Sell	-16,485	Closed	-$1.45M	–	799
2017 Q1	$1.45M	Buy	+16,485	New	+$1.47M	0.02%	239
2016 Q4	–	Sell	-7,272	Closed	-$673K	–	61
2016 Q3	$673K	Buy	+7,272	New	+$685K	0.01%	317
2015 Q1	–	Sell	-89,689	Closed	-$10.6M	–	214
2014 Q4	$10.6M	Buy	89,689 +33,110	+59%	+$2.75M	0.17%	86
2014 Q3	$4.08M	Buy	56,579 +4,800	+9%	+$315K	0.07%	109
2014 Q2	$3.22M	Buy	+51,779	New	+$3.13M	0.05%	124

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Magnetar Financial's BMRN Position: Q4 2025 in Review

Magnetar Financial sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2025, closing a stake of 12,955 shares — an estimated $702K sold.

Magnetar Financial first reported a position in BMRN in Q2 2014 and held it in 13 quarters. The position peaked at $10.6M in Q4 2014. 539 funds tracked by Wall St. Rank hold BMRN as of Q4 2025.

Magnetar Financial reported no remaining BioMarin Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Magnetar Financial sold 12,955 BioMarin Pharmaceuticals shares in Q4 2025, an estimated $702K.
Magnetar Financial first reported a position in BioMarin Pharmaceuticals in Q2 2014 and held it in 13 quarters.
Magnetar Financial's BioMarin Pharmaceuticals position peaked at $10.6M in Q4 2014.
539 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2025.

Based on Magnetar Financial's 13F filing for Q4 2025, filed 17 Feb 2026.